Tsuyoshi Eiro
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Association between Intravenous Ketamine Treatment and Cognitive Function in Patients with Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Trial.
Journal: Pharmacopsychiatry
Published: July 07, 2026
Age and sex-dependent alteration in AMPA receptor density in living human brain.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 05, 2026
Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.
Journal: Frontiers in neural circuits
Published: May 07, 2025
Systemic increase of AMPA receptors associated with cognitive impairment of long COVID.
Journal: Brain communications
Published: March 03, 2025
First-in-Human Study of 18F-Labeled PET Tracer for Glutamate AMPA Receptor [18F]K-40: A Derivative of [11C]K-2.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 20, 2024
Abnormal resting-state functional connectivity in panic disorder: An exploratory whole-brain MRI study.
Journal: Journal of affective disorders
Published: November 22, 2024
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial.
Journal: Psychiatry and clinical neurosciences
Published: May 10, 2024
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography.
Journal: Molecular psychiatry
Published: February 28, 2024
Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy.
Journal: Cell reports. Medicine
Published: December 07, 2022
First case of Myhre syndrome with schizophrenia.
Journal: Clinical dysmorphology
Published: August 30, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026